Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 2

Sponsor Class

OTHER 434INDUSTRY 102OTHER_GOV 19NIH 14NETWORK 7UNKNOWN 6FED 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 42Colonic Neoplasms 14Colonic Polyps 13Carcinoma, Hepatocellular 9Adenoma 7Rectal Neoplasms 5Liver Neoplasms 5Fibrosis 5Barrett Esophagus 5Neoplasms 4Lung Neoplasms 4Esophageal Neoplasms 4Breast Neoplasms 4Adenocarcinoma Of Esophagus 4Health Education 3Gastroesophageal Reflux 3Urinary Bladder Neoplasms 2Patient Compliance 2Ovarian Neoplasms 2Esophageal Squamous Cell Carcinoma 2Adenomatous Polyps 2Tobacco Use 1Stroke 1Renal Insufficiency, Chronic 1Rare Diseases 1Pulmonary Disease, Chronic Obstructive 1Proteinuria 1Patient Satisfaction 1Patient Preference 1Patient Acceptance of Health Care 1

Interventions

Itraconazole 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
FED × Esophageal Squamous Cell Carcinoma × Gastrointestinal × Clear all
NCT05563766 2025-11-05

A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer

VA Office of Research and Development

Phase 2 Recruiting
78 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma

NCT04018872 2021-11-04

Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer

Dallas VA Medical Center

Phase 2 Recruiting
78 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Adenocarcinoma, Carcinoma, Squamous Cell, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡